PhotoPharmics, Inc Revenue
Medical Equipment Manufacturing • 
American Fork, Utah, United States • 1-10 Employees
PhotoPharmics, Inc revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $2,500,000 |
| Total funding | $22,100,000 |
Key Contact at PhotoPharmics, Inc
Rachel Lopez
Digital Marketing Director
Company overview
| Headquarters | 947 S 500 E, American Fork, Utah 84003, US |
| Phone number | +18017706960 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Medical Devices, Neurology, Neurological Disorders, Light Therapy, Neuromodulation, Parkinson'S Disease, Phototherapy, Photo Therapy, Photoneuromodulation |
| Founded | 2011 |
| Employees | 1-10 |
| Socials |
PhotoPharmics, Inc Email Formats
PhotoPharmics, Inc uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@photopharmics.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@photopharmics.com | 80% |
{first name}.{last name} | john.doe@photopharmics.com | 20% |
About PhotoPharmics, Inc
PhotoPharmics specialize in treating neurodegenerative disorders through the eyes. We have 30+ years of research and experience in this field, developing specialized light solutions to regulate circadian rhythms for SAD, sleep disorders, anxiety, and depression (acquired by Philips-Respironics in 2007). These solutions are now used by millions. Neurodegenerative diseases show retinal deterioration, which may contribute to disease symptoms. These diseases, such as Parkinson’s disease, are also accompanied by circadian system dysregulation. Animal research and human pilot trials show that specialized wavelengths of light delivered in the right intensities and at the right time of day could reduce Parkinson’s symptoms. As a result of our work in this area, PhotoPharmics developed the use of specific wavelengths of light in Parkinson’s and conducted a pivotal human clinical trial to demonstrate its safety and efficacy. The results of the clinical trial will be published in the Autumn of 2018
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
PhotoPharmics, Inc has 5 employees across 5 departments.
Departments
Number of employees
Funding Data
Explore PhotoPharmics, Inc's funding history, including investment rounds, total capital raised, and key backers.
PhotoPharmics, Inc Tech Stack
Discover the technologies and tools that power PhotoPharmics, Inc's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Cookie compliance
Analytics
Mobile frameworks
JavaScript libraries
JavaScript libraries
Analytics
Programming languages
Security
Blogs
France
Canada
Australia
United Kingdom
Frequently asked questions
4.8
40,000 users
